Skip to Main Content

Author Details

Tori N Yamamoto
National Cancer Institute
2005
24
21
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35926468Cancer genes disfavoring T cell immunity identified via integrated systems approach.Cell Rep2022
34526724An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness.Nature2021
32511497Test performance evaluation of SARS-CoV-2 serological assays.medRxiv2020
32855547Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.Nat Biotechnol2020
32516591Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.Cancer Cell2020
30694219T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.J Clin Invest2019
31405895Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.J Exp Med2019
31591590Developing neoantigen-targeted T cell-based treatments for solid tumors.Nat Med2019
30923193T cell stemness and dysfunction in tumors are triggered by a common mechanism.Science2019
28804489Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.Front Immunol2017
29212954Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.JCI Insight2017
28783722Identification of essential genes for cancer immunotherapy.Nature2017
27626381Ionic immune suppression within the tumour microenvironment limits T cell effector function.Nature2016
26657860Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.J Clin Invest2016
28008916Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction.Nat Commun2016
24045181CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor.Clin Cancer Res2014
25384948Immunotherapy: Treatment of aggressive lymphomas with anti-CD19 CAR T cells.Nat Rev Clin Oncol2014
23412093Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.Blood2013
22031866Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.Blood2012
22545138Novel serial positive enrichment technology enables clinical multiparameter cell sorting.PLoS One2012
22214845Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.J Clin Invest2012
21461886Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.Cancer Immunol Immunother2011
20702778The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.Blood2010
15809230PIRLs: a novel class of plant intracellular leucine-rich repeat proteins.Plant Cell Physiol2005
  • 1 - 24 of 24

Recommended Authors

University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 6
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 1
Universite de Montreal
Career Start Year 2007
Number of shared co-authors 1
Stanford University
Career Start Year 2005
Number of shared co-authors 10
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 0
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 0
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 4
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
University Children's Hospital Muenster
Career Start Year 1994
Number of shared co-authors 0
University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 2
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 5
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 1
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 2
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 0
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 7
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 8

Collaborators

National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 13
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 8
Co-authored papers 3
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
Weill Institute for Neurosciences, University of California-San Francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California San Francisco School of Medicine
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
University of California-San Francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of Chicago
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
San Francisco General Hospital, University of California
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2